Recent Advances in Targeted Nanotherapeutic Approaches for Breast Cancer Management
- 2 December 2021
- journal article
- review article
- Published by Taylor & Francis in Nanomedicine
- Vol. 16 (29) , 2605-2631
Abstract
Breast cancer is the most commonly occurring tumor disease worldwide. Breast cancer is currently managed by conventional chemotherapy, which is inadequate in curbing this heterogeneous disease and ... Lay abstract Breast cancer is the most common cancer in women around the world with a high death rate. Current treatment methods are not able to cure this disease completely. Recently, nanoparticle...Keywords
This publication has 234 references indexed in Scilit:
- Targeted Drug Delivery Systems Mediated by a Novel Peptide in Breast Cancer Therapy and ImagingPLOS ONE, 2013
- The resistance of breast cancer stem cells to conventional hyperthermia and their sensitivity to nanoparticle-mediated photothermal therapyBiomaterials, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthaseBreast Cancer Research and Treatment, 2010
- Delivering nanomedicine to solid tumorsNature Reviews Clinical Oncology, 2010
- Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell ContentCell, 2010
- Targeting breast stem cells with the cancer preventive compounds curcumin and piperineBreast Cancer Research and Treatment, 2009
- Immunocompatibility properties of lipid–polymer hybrid nanoparticles with heterogeneous surface functional groupsBiomaterials, 2009
- Factors Affecting the Clearance and Biodistribution of Polymeric NanoparticlesMolecular Pharmaceutics, 2008
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005